SS
VRCA icon

Steve Schonfeld’s Verrica Pharmaceuticals VRCA Stock Holding History

Steve Schonfeld’s Portfolio VRCA Stock Details VRCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,340
Closed -$39K – 3046
2022
Q3 		$39K Sell
1,340
-1,920
-59% -$65.8K ﹤0.01% 2665
2022
Q2 		$62K Buy
+3,260
New +$164K ﹤0.01% 2197
2021
Q2 		– Sell
-4,431
Closed -$672K – 2340
2021
Q1 		$672K Buy
+4,431
New +$613K 0.01% 1040
2019
Q4 		– Sell
-12,847
Closed -$1.9M – 1502
2019
Q3 		$1.9M Buy
+12,847
New +$1.43M 0.06% 321

Other funds holding VRCA

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.79B AUM 30.56% 1-Year Est. Return
CI
Conning Inc Hartford, Connecticut $3.34B AUM 25.19% 1-Year Est. Return

Steve Schonfeld's VRCA Position: Q4 2022 in Review

Steve Schonfeld sold out of Verrica Pharmaceuticals (VRCA) in Q4 2022, closing a stake of 1,340 shares — an estimated $39K sold.

Steve Schonfeld first reported a position in VRCA in Q3 2019 and held it in 4 quarters. The position peaked at $1.9M in Q3 2019. 50 funds tracked by Wall St. Rank hold VRCA as of Q4 2022.

  • Steve Schonfeld reported no remaining Verrica Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • Steve Schonfeld sold 1,340 Verrica Pharmaceuticals shares in Q4 2022, an estimated $39K.
  • Steve Schonfeld first reported a position in Verrica Pharmaceuticals in Q3 2019 and held it in 4 quarters.
  • Steve Schonfeld's Verrica Pharmaceuticals position peaked at $1.9M in Q3 2019.
  • 50 funds tracked by Wall St. Rank held Verrica Pharmaceuticals as of Q4 2022.

Based on Schonfeld Strategic Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.